Indiziert in
- Öffnen Sie das J-Tor
- Akademische Schlüssel
- RefSeek
- Hamdard-Universität
- EBSCO AZ
- OCLC – WorldCat
- Publons
- Euro-Pub
- Google Scholar
Nützliche Links
Teile diese Seite
Zeitschriftenflyer
Open-Access-Zeitschriften
- Allgemeine Wissenschaft
- Biochemie
- Bioinformatik und Systembiologie
- Chemie
- Genetik und Molekularbiologie
- Immunologie und Mikrobiologie
- Klinische Wissenschaften
- Krankenpflege und Gesundheitsfürsorge
- Landwirtschaft und Aquakultur
- Lebensmittel & Ernährung
- Maschinenbau
- Materialwissenschaften
- Medizinische Wissenschaften
- Neurowissenschaften und Psychologie
- Pharmazeutische Wissenschaften
- Umweltwissenschaften
- Veterinärwissenschaften
- Wirtschaft & Management
Abstrakt
Clinical Implication of SGLT-2 Inhibitors on Diuretics Dose in Outpatient Heart Failure Patients
Bong-Joon Kim
Inhibitors of Sodium Glucose Co-transporter 2 (SGLT-2) reduce the risk of hospitalization for heart failure. Recent studies showed evidence supporting the effects of SGLT-2 inhibitors on broad spectrum of Heart Failure (HF) regardless of left ventricular ejection fraction. There have been many changes in the guideline if HF and several studies of SGLT-2 have played a key role.
In stable outpatients HF patients, the event such as cardiovascular death or HF hospitalization is less likely to occur. So, intensification of diuretic therapy also is a representative indicator of worsening HF. The current study’s objective was to examine the effect of SGLT-2 inhibitors on change of diuretics dose in outpatient HF patients.